From: Safety and effectiveness of the SUPRACOR presbyopic LASIK algorithm on hyperopic patients
MRSE | Group A Dominant (Supracor) | Group A Non Dominant (Supracor) | Group B Dominant (LASIK) | Group B Non-Dominant (Supracor) | Group C Dominant (No treatment) | Group C Non-Dominant (Supracor) |
---|---|---|---|---|---|---|
Pre-Op | 1.81 ± 0.32 | 1.76 ± 0.38 | 1.63 ± 0.46 | 1.81 ± 0.72 | 0.76 ± 0.38 | 0.78 ± 0.48 |
1 month | −0.39 ± 0.55 | −0.51 ± 0.61 | −0.16 ± 0.37 | −1.06 ± 0.78 | 0.68 ± 0.44 | −0.78 ± 0.59 |
3 months | −0.32 ± 0.40 | −0.53 ± 0.42 | 0.10 ± 0.31 | −0.76 ± 0.63 | 0.66 ± 0.39 | −0.51 ± 0.60 |
6 months | −0.47 ± 0.24 | −0.59 ± 0.64 | 0.01 ± 0.21 | −0.55 ± 0.63 | 0.60 ± 0.46 | −0.45 ± 0.38 |